Arrowhead Pharmaceuticals Director Sells $1 Million Worth of Shares
Michael S. Perry, a director at Arrowhead Pharmaceuticals (NASDAQ: ARWR), sold 11,600 shares on August 18, 2026, for approximately $1 million based on an average sale price of $87.30 per share. The transaction reduced his direct holdings by about 9%, leaving him with a remaining stake valued at around $9.8 million as of the same day's market close. The company has a current market capitalization of approximately $12.6 billion, and its shares closed at $89.41 on August 19, 2026. Arrowhead Pharmaceuticals reported trailing twelve-month revenue of $669.5 million but also recorded a net loss of $320 million during the same period. This insider transaction appears to be part of routine portfolio management rather than an indication of negative sentiment toward the company's prospects, especially given that Perry still holds significant equity and unvested restricted stock units.
Tickers: $ARWR
Topics: Arrowhead Pharmaceuticals insider selling stock transactions